homepee.com

ÇÐȸ ¹× ÈÄ¿ø

ÇÐȸ ¹× ÈÄ¿ø

¡å

  • CUSTOMER
  • 02-3425-1139
  • am 08:00 ~ pm 06:00
¿Â¶óÀι®ÀÇ
  • Home
  • ÇÐȸ ¹× ÈÄ¿ø
  • ICNIM

ICNIMÇÐȸ ¹× ÈÄ¿ø

Á¦¸ñ Á¦11ȸ AHCC ¿¬±¸È¸ ±¹Á¦È¸ÀÇ
ÀÛ¼ºÀÚ KCFKOREA
ÀÛ¼ºÀÏÀÚ 2019-04-09
 


 
 

Á¦11ȸ AHCC ¿¬±¸È¸ ±¹Á¦È¸ÀÇ  
°³ÃÖ Àå¼Ò : »ñÆ÷·Î½Ã(·ÎÀÌÆ° »ñÆ÷·Î)   
ÁÖÃÖ : AHCC ¿¬±¸È¸   
ÈÄ¿ø : °æÁ¦ »ê¾÷¼º ȪīÀ̵µ °æÁ¦ »ê¾÷±¹, ÁÖ½Äȸ»ç ¾Æ¹Ì³ë¾÷È­ÇР
 
 
 
AHCC¸¦ ¿¬±¸ÇÏ°í ÇÑ ÇØ µ¿¾ÈÀÇ ¿¬±¸, Á¤º¸, ¼º°ú¸¦ ¹ßÇ¥ÇÏ´Â
AHCC ¿¬±¸È¸°¡ ¿ÃÇØ¿¡µµ ¸·À» ¿­¾ú½À´Ï´Ù.
À̹ø AHCC ¿¬±¸È¸´Â Á¦11ȸ AHCC ¿¬±¸È¸ ±¹Á¦ÇÐȸÀÔ´Ï´Ù.

À̹øÁ¦ 11Â÷ AHCC ¿¬±¸È¸ ±¹Á¦ÇÐȸ¿¡¼­´Â
½ºÆ®·¹½º¿Í ´ç´¢º´¿¡ °üÇÑ ¿¬±¸º¸°í°¡ ¸¹Àº ÀÇ·á°ü°èÀÚµéÀÇ ´«±æÀ» ²ø¾ú½À´Ï´Ù.
½ºÆ®·¹½º´Â ¸¸º´ÀÇ ±Ù¿øÀ¸·Î Çö´ë»çȸ¿¡¼­ »©³õÀ» ¼ö ¾ø´Â ¸¸Å­, ´õ¿í´õ ¸¹Àº °ü°èÀÚµéÀÇ ÁÖ¸ñÀ» ¹Þ¾Ò½À´Ï´Ù.
 
 
 
 
Keynote Lecture

¡°Space Flight, the Immune System and Resistance to Infection¡±
Gerald Sonnenfeld £¨Morehouse School of Medicine, USA£©
 
General Lecture

¡°The Antitumor Effect of Genistein Combined Polysaccharide (GCP) on Subcutaneous Tumor Bearing Mice¡±
Dong Nie, et al. £¨Osaka University, Japan£©
¡°Effects of GCP and AHCC on Diabetic and Diabetic Retinopathy in Spontaneously Diabetic SDT Rat: a Pilot Study¡±
Gang Miao, et al. £¨Osaka University, Japan£©
¡°Study on the Mechanism of GCP on Induction of Apoptosis in ISOS-1 Cells¡±
Koji Wakame, et al. £¨Amino Up Chemical Co., Ltd., Japan£©
¡°Genistein Combined Polysaccharide: A Nutritional Supplement with Potent Anti-Bladder Cancer Activity¡±
D.L. Bemis, et al. £¨Columbia University, USA£©
¡°GCP and Prostate Cancer: A Human Clinical Trial¡±
Robert M. Hackman, et al. £¨University of California, Davis, USA£©
¡°A Clinical Evaluation for Using AHCC and GCP in Lung Cancer and Breast Cancer Patients¡±
Reiki Ishizuka, et al. £¨Tajima Clinic, Japan£©
¡°The Effect of GCP on Menopausal Symptoms¡±
Jun-Yeong Choi £¨Gachon Medical School, Korea£©
¡°Effect of AHCC on Reduction of Cisplatin-Induced Toxicity to Digestive Tracts¡±
Satoru Yui, et al. £¨Teikyo University, Japan£©
¡°Host Conditions Allowing Oral AHCC Administration to Display Its Effectiveness for Experimental Murine Tumor and Infection Models¡±
Shigeru Abe, et al. £¨Teikyo University, Japan£©
¡°Amelioration by AHCC of endocrine disturbances induced by oxidative stress in the rat¡±
She-fang Ye, et al. £¨Dokkyo University, Japan£©
¡°AHCC Enhances Tumor Immunosurveillance by Up-regulating the Antigen-specific CD8+ IFN-¥ã Production¡±
Zhinan Yin, et al. £¨Yale School of Medicine, USA£©
¡°Resistance to Klebsiella pneunoniae Infection Is Enhanced by Active Hexose Correlated Compound (AHCC) in the Hindlimb-Unloading Rodent Model of Space Flight¡±
Hernan Aviles, et al. £¨Morehouse School of Medicine, USA£©
¡°Effect of AHCC (Active Hexose Correlated Compound) as an Adjuvant Therapy of the Local Treatment of Hepatocellular Carcinoma on Hepatic Reserve Function¡±
Chizu Koreeda, et al. £¨Kansai Medical University, Japan£©
¡°The significance of functional food as immunotherapy¡±
Yusai Kawaguchi, et al. £¨Kansai Medical University, Japan£©
¡°A Report on the Progressing Status of a Randomized Double Blind Clinical Trial for the Effect of GCP on Digestive Trace Cancer¡±
Kayoko Amemori, et al. £¨Kansai Medical University, Japan£©
¡°The effect of AHCC as a post-operation therapy in hepatocellular carcinoma¡±
Youichi Matui, et al. £¨Kansai Medical University, Japan£©
¡°AHCC Treatment in Postoperative Cholangioma Patients¡±
Naoyoshi Terakawa, et al. £¨Kansai Medical University, Japan£©
¡°The Change of Immune Parameters before and after AHCC Intake in Healthy Volunteers¡±
Hiroaki Yanagimoto, et al. £¨Kansai Medical University, Japan£©
¡°Study on chemoprevention of Active Hexose Correlated Compound in high risk group for liver cancer development¡±
Petcharin Srivatanakul, et al. £¨National Cancer Institute, Thailand£©
¡°Determination of IFN-¥ã and IL-12 in AHCC-Supplemented Patients with Advance Hepatic Cancer Preliminary Report¡±
Suphon Manoromana, et al. £¨National Cancer Institute, Thailand£©
¡°New Clinical Uses for AHCC¡±
Fred Pescatore £¨The Center for Integrative and Complementary Medicine, USA£©
¡°The Design and Evaluation of a Clinical Trial: A Proposed Double-Blind Placebo-Controlled Trial of AHCC as Adjunctive Treatment in Patients Receiving Standard Immunotherapy for Hepatitis C¡±
Thomas Walshe £¨Harvard Medical School, USA£©
 
 

 
Á¶È¸¼ö 206

INFORMATION
  • ȸ»ç¸í : ÄÉÀ̾¾¿¡ÇÁÄÚ¸®¾Æ
  • ´ëÇ¥ÀÚ¸í : ±è°ÇÁ¾
  • ÁÖ¼Ò : ¼­¿ï½Ã ±¤Áø±¸ ¶Ò¼¶·Î 700, 202È£
  • ´ëÇ¥ÀüÈ­ : 02-3425-1139
  • ´ëÇ¥ÀüÈ­ : 02-3425-1139
LICENCE
  • »ç¾÷ÀÚµî·Ï¹øÈ£ : 220-81-86504
WEB MASTER
  • e-mail : customer@kcfkorea.com
  • °³ÀÎÁ¤º¸º¸È£Á¤Ã¥ Ã¥ÀÓÀÚ : ±è¸íÈñ
SITEMAP
¸ðµç ÄÁÅÙÃ÷ÀÇ ¹«´ÜÀüÁ¦ ¹× ¸µÅ©¸¦ ±ÝÁöÇÕ´Ï´Ù.
Copyright(c) 1989 by KCFKOREA All Rights Reserved. Designed by www.raphaheal.com